These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 9005786)

  • 21. [Clinical and pharmacokinetic evaluation of ofloxacin under various regimens of administration in patients with bronchopulmonary infections].
    Belousov OB; Gutkin AB; Sokolov AV; Tishchenkova IF; Efremenkova OV
    Antibiot Khimioter; 1996; 41(9):47-9. PubMed ID: 9005786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
    Thys JP; Jacobs F; Byl B
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):304-15. PubMed ID: 1864291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ten-year experience with the use of ofloxacin (Tarivid*). New treatment regimens].
    Navashin SM; Navashin PS; Smirnova LB
    Antibiot Khimioter; 1996; 41(9):99-103. PubMed ID: 9005800
    [No Abstract]   [Full Text] [Related]  

  • 24. [The first 'respiration' fluoroquinolone--levofloxacin (Tavanic) in therapy of bacterial infections. Pharmacodynamics principles in optimization of administration regimens].
    Budanov SV; Vasil'ev AN; Smirnova LB
    Antibiot Khimioter; 2001; 46(7):38-46. PubMed ID: 11697244
    [No Abstract]   [Full Text] [Related]  

  • 25. [Role of therapeutic drug monitoring in pulmonary infections].
    Padoin C
    Rev Mal Respir; 2017 Jun; 34(6):693-705. PubMed ID: 28528008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.